Company news
Modular Medical, Inc. (NASDAQ:MODD) news
Every Modular Medical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
September 4, 2026
Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
September 3, 2026
Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
August 3, 2026
Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
July 23, 2026
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
July 14, 2026
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
July 1, 2026
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
June 30, 2026
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
June 26, 2026
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
June 24, 2026
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
June 4, 2026
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
April 19, 2026
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 16, 2026
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
April 9, 2026
Modular Medical Announces 1-for-30 Reverse Stock Split
March 26, 2026
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
March 3, 2026
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
February 4, 2026
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
December 31, 2025
Modular Medical Announces Pricing of $4.68 Million Public Offering
December 10, 2025
Modular Medical Announces Proposed Public Offering
December 9, 2025
Modular Medical Announces Proposed Public Offering
December 9, 2025
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
November 17, 2025
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
November 14, 2025
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
November 3, 2025
Modular Medical Announces Ongoing Progress to Obtain CE Mark
October 28, 2025
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
October 6, 2025
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
September 29, 2025
Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study
September 15, 2025
Modular Medical Announces Completion of Clinical Study of MODD1 Pump
September 11, 2025
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
August 26, 2025
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
August 8, 2025
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
August 6, 2025
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
August 4, 2025
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions
June 16, 2025
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
May 28, 2025
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
May 22, 2025
Modular Medical Announces $12 Million Private Placement
March 20, 2025
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
January 30, 2025
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
December 19, 2024
Modular Medical Announces Conference Call to Provide Business Update
December 3, 2024
Modular Medical : Announces Proposed Public Offering Form 8 K
November 25, 2024
Modular Medical Announces Pricing of $8.2 Million Public Offering
November 21, 2024
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
November 11, 2024
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
November 7, 2024
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
September 30, 2024
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
September 18, 2024
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
September 11, 2024
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
September 4, 2024
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
September 4, 2024
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
August 7, 2024
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
July 15, 2024